D. Basu

Activated NKT Cells and NK Cells Render T Cells Resistant to Myeloid-Derived Suppressor Cells and Result in an Effective Adoptive Cellular Therapy against Breast Cancer in the FVBN202 Transgenic Mouse

Lisa L. Smith, H. Bear, A. Yacoub, 2011, The Journal of Immunology.

EX VIVO EXPANSION OF TUMOR-SPECIFIC T CELLS WITH SEQUENTIAL COMMON GAMMA CHAIN CYTOKINES RENDER THEM REFRACTORY TO MDSC UPON ADOPTIVE IMMUNOTHERAPY.

D. Basu, 2010 .

Adjuvant atezolizumab versus placebo for patients with renal cell carcinoma at increased risk of recurrence following resection (IMmotion010): a multicentre, randomised, double-blind, phase 3 trial

B. Rini, V. Master, R. Uzzo, 2022, The Lancet.

Cancer in the FVBN202 Transgenic Mouse Adoptive Cellular Therapy against Breast Suppressor Cells and Result in an Effective Cells Resistant to Myeloid-Derived Activated NKT Cells and NK Cells Render T

Lisa L. Smith, H. Bear, A. Yacoub, 2011 .